AI’s role on the cost-effectiveness of cancer diagnosis and treatment

The cost-effectiveness of treatment is also a concern. Cancer medicine spending rose to $185 billion globally in 2021, with 74% of that in major developed markets. Ensuring broad and fair access to these treatments remains a major challenge. On average, a patient's cancer treatment expenses total around $150,000. Cancer care costs are soaring: $185B spent in 2021, average patient costs near $150K, and a projected $25.2T global economic hit by 2050. High prices threaten access—demanding value-based, equitable oncology solutions. #healthcarecosts #oncology #economics #valuebasedcare